Skip to content

Effects of Adrenergic Drugs on the Fluid Balance During Surgery

The Effects of ß1-receptor Blockade and α1-adrenergic Agonist on the Kinetics of Lactated Ringer's Solution During Surgery

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01431612
Enrollment
60
Registered
2011-09-09
Start date
2008-11-30
Completion date
2010-10-31
Last updated
2011-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cyst

Keywords

Pharmacokinetics, kidney;, Receptors, adrenergic;, Fluids, i.v.;, Sympathetic nervous system, esmolol;, Sympathetic nervous system, phenylephrine

Brief summary

The aim this study was to examine to what degree the slow turnover of lactated Ringer's solution during anesthesia and surgery can be prevented by infusing esmolol (a ß1-receptor blocker) or phenylephrine in patients undergoing laparoscopic gynecological surgery performed under intravenous anesthesia.

Detailed description

INTRODUCTION The renal clearance of infused crystalloid fluid is very low during anaesthesia and surgery, but experiments in conscious sheep indicate that the renal fluid clearance might approach a normal rate when the adrenergic balance is modified. METHODS Sixty females (mean age, 32 years) undergoing laparoscopic gynecological surgery were randomized to control group and received only the conventional anesthetic drugs and 20 ml/kg of lactated Ringer's over 30 min. The others were also given an infusion of 50 µg/kg/min of esmolol (beta1-receptor blocker) or 0.01 µg/kg/min of phenylephrine (alpha1-adrenergic agonist) over 3 hours. The distribution and elimination of infused fluid was studied by volume kinetic analysis based on urinary excretion and blood Hgb level.

Interventions

50 µg/kg/min of the ß1-receptor-blocker esmolol was infused intravenous over 3 hours

0.01 µg/kg/min of the alpha-1-adrenergic receptor agonist phenylephrine

DRUGLactated Ringer´s solution

Intravenous Infusion of 10 ml/h lactated Ringer's solution that contained no drug

Sponsors

Zhejiang University
CollaboratorOTHER
Sodertalje Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* ASA group I * Scheduled for laparoscopic removal of ovarian cyst or laparoscopic hysterectomy

Exclusion criteria

* ASA group \> I * Daily medication

Design outcomes

Primary

MeasureTime frameDescription
Urinary excretion3 hoursUrine was collected via an indwelling catheter during 3 hours of surgery

Secondary

MeasureTime frameDescription
Volume kinetics of lactated Ringer´s solution3 hoursVolume kinetics was analyzed based on serial analysis of the blood Hgb concentration and the collection of urine. Distribution between a central body and a peripheral body fluid space was then calculated over time.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026